NCT04306276View on ClinicalTrials.gov

Pretreatment With Dienogest in Women With Endometriosis Undergoing in Vitro-fertilization After a Previous Failed Cycle

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
EndometriosisEndometriosis OvaryIVF
Interventions
DRUG

Dienogest 2 MG

Three-month treatment with DNG (2 mg daily; Visanne, Bayer Pharma, Germany) before IVF

Trial Locations (1)

16132

IRCCS Ospedale Policlinico San Martino, Genoa

All Listed Sponsors
lead

Ospedale Policlinico San Martino

OTHER

NCT04306276 - Pretreatment With Dienogest in Women With Endometriosis Undergoing in Vitro-fertilization After a Previous Failed Cycle | Biotech Hunter | Biotech Hunter